Add-on effect of Brahmi in the management of schizophrenia
نویسندگان
چکیده
Brahmi(Bacopa monnieri), an Ayurvedic herb has primarily been used to enhance cognitive ability, memory and learning skills. We present a case study of schizophrenia in which add-on Brahmi extracts 500 mg/day for a period of one month resulted in reduction in psychopathology without any treatment-emergent adverse effect. Although preliminary, our case study suggests therapeutic efficacy of add-on Brahmi in schizophrenia, thus opening up a new dimension of its role in alternative medicines.
منابع مشابه
Evaluating the Efficacy of Vitamin D Add-on Therapy on Treatment of Positive, Negative and Cognitive Symptoms in Patients with Chronic Schizophrenia; A Double Blind Clinical Trial
Background: Vitamin D can be effective in treating some symptoms of schizophrenia, and with better control of vitamin D levels and supplementation, there is a potential for reducing this disease. But due to small number of studies, more studies are needed in this area. The aim of this study was to determine the efficacy of vitamin D as an adjunct to the positive, negative, and cognitive symptom...
متن کاملThe Effect of Stress Management Training on Positive Experiences of Families Caring for Patients with Schizophrenia
Background: Living with schizophrenic patients and its associated stress and negative psychological burden can bring about different experiences for their families. The provision of stress management training for these families can be helpful in increasing self-confidence and enhancing interpersonal communication in these caregivers, which can improve their mental health status and enhance the ...
متن کاملEvaluation of the efficacy and safety of pregabalin as an adjuvant to antipsychotics in patients with chronic schizophrenia: a six-week pilot double-blind placebo-controlled trial
Introduction and objectives: Antipsychotics or dopamine receptor antagonists are the major components of treatment but about 10-20% of patients with schizophrenia do not benefit from treatment with antidopaminergic agents, indicating other neuronal systems may be involved in this disorder (2). Dysregulation of both excitatory and inhibitory mechanisms N-Methyl-D-aspartic acid (NMDA) and γ-Amino...
متن کاملاثر درمانی ریلوزول بهعنوان درمان کمکی در بهبود علائم افراد مبتلا به اسکیزوفرنی نوع مداوم
Background & Aims: This study was aimed to evaluate the efficacy of riluzole (a glutamate release inhibitor) add-on therapy in the treatment of negative symptoms of patients with chronic schizophrenia. Materials & Methods: This randomized, double-blind, and placebo-controlled study was conducted on thirty patients with continues schizophrenia (DSM-IV-TR) that were randomized considering eith...
متن کاملPm536. Bacopa Monnieri (brahmi) Can Recover and Prevent Cognitive Deficit in Sub-chronic Phencyclidine Rat Model of Schizophrenia by Elevating Vesicular Glutamate Transporter Type 3 in the Brain
s | 95 (F = 5.812, P < 0.05). In addition, response bias was significantly reduced after bilateral saccadic eye movements relative to that after eye fixation (F = 10.366, P < 0.01). Statistically significant interaction effects were not observed between eye movement conditions and face emotion types. Conclusion: The present study showed that bilateral saccadic eye movements enhanced the per...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره 3 شماره
صفحات -
تاریخ انتشار 2012